LOM Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$601K Sell
16,350
-100
-0.6% -$4.74K 0.17% 119
2025
Q4
$837K Sell
16,450
-40
-0.2% -$2.04K 0.24% 105
2025
Q3
$915K Buy
16,490
+15,425
+1,448% +$903K 0.28% 100
2025
Q2
$74K Buy
+1,065
New +$72.4K 0.03% 170

Other funds holding NVO

LOM Asset Management's NVO Position: Q1 2026 in Review

LOM Asset Management reduced its Novo Nordisk (NVO) stake by 0.61% in Q1 2026, selling an estimated $4.74K and leaving 16,350 shares worth $601K. The position accounts for 0.17% of the portfolio, ranked #119.

LOM Asset Management first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $915K in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • LOM Asset Management held 16,350 shares of Novo Nordisk worth $601K as of Q1 2026.
  • LOM Asset Management sold 100 Novo Nordisk shares in Q1 2026, an estimated $4.74K.
  • Novo Nordisk made up 0.17% of LOM Asset Management's portfolio in Q1 2026, its #119 holding.
  • LOM Asset Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • LOM Asset Management's Novo Nordisk position peaked at $915K in Q3 2025.
  • 1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on LOM Asset Management's 13F filing for Q1 2026, filed 5 May 2026.